PubMed (GeneRIF) for id: 976

Year	Number of Results
2001	1
2002	1
2004	1
2005	2
2006	2
2007	1
2008	2
2009	3
2010	6
2011	3
2012	5
2013	5
2014	3
2015	5
2016	2
2017	3
2018	3
2019	6
2020	2
2021	3
2022	4
2023	3
2024	1

1

Conformational transitions and activation of the adhesion receptor CD97.

Mao C, Zhao RJ, Dong YJ, Gao M, Chen LN, Zhang C, Xiao P, Guo J, Qin J, Shen DD, Ji SY, Zang SK, Zhang H, Wang WW, Shen Q, Sun JP, Zhang Y. Mao C, et al. Mol Cell. 2024 Feb 1;84(3):570-583.e7. doi: 10.1016/j.molcel.2023.12.020. Epub 2024 Jan 11. Mol Cell. 2024. PMID: 38215752

2

The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability.

Ravn-Boess N, Roy N, Hattori T, Bready D, Donaldson H, Lawson C, Lapierre C, Korman A, Rodrick T, Liu E, Frenster JD, Stephan G, Wilcox J, Corrado AD, Cai J, Ronnen R, Wang S, Haddock S, Sabio Ortiz J, Mishkit O, Khodadadi-Jamayran A, Tsirigos A, Fenyö D, Zagzag D, Drube J, Hoffmann C, Perna F, Jones DR, Possemato R, Koide A, Koide S, Park CY, Placantonakis DG. Ravn-Boess N, et al. Cell Rep. 2023 Nov 28;42(11):113374. doi: 10.1016/j.celrep.2023.113374. Epub 2023 Nov 8. Cell Rep. 2023. PMID: 37938973 Free PMC article.

3

IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-PI3K/AKT signaling upon CD97 activation.

Meng ZW, Zhang L, Cai XR, Wang X, She FF, Chen YL. Meng ZW, et al. Sci Rep. 2023 Oct 31;13(1):18711. doi: 10.1038/s41598-023-45496-3. Sci Rep. 2023. PMID: 37907543 Free PMC article.

4

Structural basis of CD97 activation and G-protein coupling.

Wang N, Qian Y, Xia R, Zhu X, Xiong Y, Zhang A, Guo C, He Y. Wang N, et al. Cell Chem Biol. 2023 Nov 16;30(11):1343-1353.e5. doi: 10.1016/j.chembiol.2023.08.003. Epub 2023 Sep 5. Cell Chem Biol. 2023. PMID: 37673067

5

CD97 expression level and its effect on cell adhesion in Preeclampsia.

Atigan A, Tan S, Cetin H, Guler OT, Ozdamar S, Karakaya YA. Atigan A, et al. BMC Pregnancy Childbirth. 2022 Dec 26;22(1):967. doi: 10.1186/s12884-022-05280-z. BMC Pregnancy Childbirth. 2022. PMID: 36572878 Free PMC article.

6

CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma.

Su Q, Li L, Li X, Li W, Zhang X, Dong Y, Han L, Wang D, Ran J. Su Q, et al. World J Surg Oncol. 2022 Dec 4;20(1):382. doi: 10.1186/s12957-022-02829-2. World J Surg Oncol. 2022. PMID: 36464675 Free PMC article.

7

To Detach, Migrate, Adhere, and Metastasize: CD97/ADGRE5 in Cancer.

Aust G, Zheng L, Quaas M. Aust G, et al. Cells. 2022 May 4;11(9):1538. doi: 10.3390/cells11091538. Cells. 2022. PMID: 35563846 Free PMC article. Review.

8

CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma.

Safaee MM, Wang EJ, Jain S, Chen JS, Gill S, Zheng AC, Garcia JH, Beniwal AS, Tran Y, Nguyen AT, Trieu M, Leung K, Wells J, Maclean JM, Wycoff K, Aghi MK. Safaee MM, et al. Sci Rep. 2022 Jan 27;12(1):1464. doi: 10.1038/s41598-022-05259-y. Sci Rep. 2022. PMID: 35087132 Free PMC article.

9

Genetic manipulation of adhesion GPCR CD97/ADGRE5 modulates invasion in patient-derived glioma stem cells.

Eichberg DG, Slepak TI, Pascoini AL, Komotar RJ, Ivan ME. Eichberg DG, et al. J Neurooncol. 2021 Jul;153(3):383-391. doi: 10.1007/s11060-021-03778-8. Epub 2021 May 24. J Neurooncol. 2021. PMID: 34028660

10

Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs.

Niu M, Xu S, Yang J, Yao D, Li N, Yan J, Zhong G, Song G. Niu M, et al. J Biol Chem. 2021 Jan-Jun;296:100776. doi: 10.1016/j.jbc.2021.100776. Epub 2021 May 14. J Biol Chem. 2021. PMID: 33992645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year